» Articles » PMID: 38057723

A Population-based Analysis of Hematological Malignancies from a French-West-Indies Cancer Registry's Data (2009-2018)

Abstract

Background: A worldwide increased incidence of HM has been marked in recent decades. Therefore, to update epidemiological characteristics of HM in a French West Indies territory, we have performed analysis through Martinique's population-based cancer registry database.

Methods: We included cancer case data, from 2009-2018, coded in strict compliance with international standards set by International Agency for Research on Cancer. We calculated standardized incidence rates, cumulative rate (ages 0-74), and temporal trends for cases and deaths using the global population standard, by sex and five age group. Mortality rates were obtained from the French Epidemiology Center on Medical Causes of Death (CépiDc).

Results: One thousand forty seven new cases and 674 deaths from HM were recorded, of which 501 MM (47.8%), 377 LMNH (36%), 123 LAM (11.8%), and 46 LH (4.4%) were reported in both sexes. MM is one of the hematological malignancies with the highest incidence in Martinique among men. Temporal trends of incidence rates for all HM decreased overall in both sexes, except for MM in men. There is significant variability in mortality rates for both sexes. In addition, over the period, the temporal trends of mortality rates for all HMs has decreased overall. Gender-specific rates, between 2009 and 2018, showed that all lymphoid HM have a multimodal distribution curve that increased with age.

Conclusions: Characteristics of HM in Martinique over the reporting periods differ from mainland France. Higher incidences have been observed, particularly for MM, and non-significant sub-mortality is observed compared to mainland France. Moreover, temporal distribution of mortality and incidence trends had decreased over the reporting periods except for MM. Our results showed similarities with African-Americans groups in United States and in particular an equivalence in the frequency distribution of diagnosed HM. However, SMR remains lower compared to US black ethnic groups. Our results contributed to expanding knowledge on the epidemiology of HM with Caribbean data.

Citing Articles

Geographical disparities in cancer and occupational exposure to pesticides in a French-West Indies territory (2006-2019).

Houpert R, Veronique-Baudin J, Almont T, Beaubrun-Renard M, Boullard M, Pierre-Louis A BMC Cancer. 2024; 24(1):1500.

PMID: 39639185 PMC: 11619627. DOI: 10.1186/s12885-024-13221-6.


Infectious Diseases and Secondary Antibody Deficiency in Patients from a Mesoregion of São Paulo State, Brazil.

Prestes-Carneiro L, Carrilho P, Torelli D, Bressa J, Parizi A, Vieira P Trop Med Infect Dis. 2024; 9(5).

PMID: 38787037 PMC: 11125600. DOI: 10.3390/tropicalmed9050104.

References
1.
Orem J, Mbidde E, Lambert B, de Sanjose S, Weiderpass E . Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007; 7(3):166-75. PMC: 2269718. DOI: 10.5555/afhs.2007.7.3.166. View

2.
Goldin L, Bjorkholm M, Kristinsson S, Turesson I, Landgren O . Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009; 146(1):91-4. PMC: 2702464. DOI: 10.1111/j.1365-2141.2009.07721.x. View

3.
Ekstrom-Smedby K . Epidemiology and etiology of non-Hodgkin lymphoma--a review. Acta Oncol. 2006; 45(3):258-71. DOI: 10.1080/02841860500531682. View

4.
Liu W, Liu J, Song Y, Zeng X, Wang X, Mi L . Burden of lymphoma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016. J Hematol Oncol. 2019; 12(1):115. PMC: 6862726. DOI: 10.1186/s13045-019-0785-7. View

5.
Passweg J, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte R . Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant. 2013; 48(9):1161-7. PMC: 3763517. DOI: 10.1038/bmt.2013.51. View